id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1976-N-0027-0008,FDA,FDA-1976-N-0027,Letter from FDA/CDER to Bayer Corporation,Other,Letter(s),2002-11-27T05:00:00Z,2002,11,,,2015-10-29T19:49:11Z,,0,0,090000648051b762